Relmada Therapeutics Inc. – Filings and Transcripts

NASDAQ: RLMD
Share price (10/2/26): $3.60
Market cap (10/2/26): $384 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Automatic shelf registration

Prospectus supplement

Shelf registration

Prospectus supplement for primary offering

Ownership Filter

Traversa Sergio

Squadron Capital Management LLC

Millennium Management LLC

News Filter

Reports Second Quarter 2026 Financial Results and Provides Business Update

Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Financial Statements or Exhibits

Reports First Quarter 2026 Financial Results and Provides Business Update

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC